Dec 22, 2014 at 10:51 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com suggests buying Wockhardt.
Dec 16, 2014 at 11:18 | Source: CNBC-TV18
Wockhardt has had a fair share of difficult times too. In 2008, the pharma companys net worth had eroded to near bankruptcy. Global financial crisis and major foreign exchange losses had hurt it as well. To tide over the crisis, the company decided to go in for CDR in 2009.
Dec 11, 2014 at 15:50 | Source: CNBC-TV18
Sharmila Joshi of sharmilajoshi.com is of the view that one can stay invested in Wockhardt as the stock may go upto Rs 1200 in a year time.
Dec 11, 2014 at 15:21 | Source: CNBC-TV18
Watch the interview of Sharmila Joshi of Sharmilajoshi.com who shared her readings and outlook on specific stocks and sector & Harsh Roongta, Director of Apnapaisa.com answered few personal finance queries.
Dec 11, 2014 at 14:47 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com recommends buying Wockhardt and JSW Energy and advises selling Reliance Infrastructure.
Dec 11, 2014 at 10:19 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com is upbeat on Wockhardt.
Dec 11, 2014 at 10:14 | Source: CNBC-TV18
Here are top 10 stocks to watch on December 11 - Sun Pharma, Wockhardt, Tech Mahindra, Jet Airways, Eicher Motor, JBF Industries, Shreyas Shipping, IOB, Allahabad Bank and Jubilant Food.
Dec 11, 2014 at 09:16 | Source: CNBC-TV18
According to Sudarshan Sukhani of s2analytics.com one must avoid trading the banks and the Bank Nifty today if it is choppy. It is better to trade individual bank stocks than the Bank Nifty, he adds.
Dec 10, 2014 at 09:11 | Source: CNBC-TV18
At the moment, the environment is such that valuations are still high and no economic recovery has been seen on the growth. At the same time, fund flows are good, but earnings growth assumptions need to be more realistic, says Anand Tandon
Dec 05, 2014 at 13:46 | Source: CNBC-TV18
Mayuresh Joshi, VP- Institution at Angel Broking is of the view that Ipca Labs is the preferred bet from the midcap pharma space.